"The Clinical Research Center is dedicated to the investigation of medications and devices under the auspices of the pharmaceutical industry."

During the past decade, St. Louis Center For Clinical Research conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 34 clinical trials were completed, i.e. on average, 141.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 15 clinical trials were completed. i.e. 187.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Louis Center For Clinical Research" #1 sponsor was "Meda Pharmaceuticals" with 8 trials, followed by "Sunovion" with 6 trials sponsored, "Bausch Health Americas, Inc." with 5 trials sponsored, "AstraZeneca" with 4 trials sponsored and "Novartis" with 4 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Louis Center For Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "RTI Health Solutions" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "St. Louis Center For Clinical Research" are "Asthma" (17 trials), "Ulcerative Colitis" (8 trials), "Crohn's Disease" (6 trials), "Perennial Allergic Rhinitis" (6 trials) and "Seasonal Allergic Rhinitis" (6 trials). Many other conditions were trialed in "St. Louis Center For Clinical Research" in a lesser frequency.

Most popular intervention types in "St. Louis Center For Clinical Research" are "Drug" (73 trials), "Other" (6 trials), "Biological" (4 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "fluticasone propionate" (3 trials), "0.15% azelastine hydrochloride" (2 trials), "Asimadoline" (2 trials) and "BLU-5937" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Louis Center For Clinical Research" are 78 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St. Louis Center For Clinical Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in St. Louis Center For Clinical Research, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in St. Louis Center For Clinical Research, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".